The rHA 20% product, derived from yeast, is a highly purified alternative to human serum albumin, matching it structurally ...

Shilpa Medicare Ltd announces that the results of its Phase I clinical trials were accepted by Subject Expert Committee ...

Shilpa Medicare's Recombinant Human Albumin 20% (rHA) is derived from yeast and offers a highly purified, structurally and ...

In relation to the successful completion of Phase I clinical trials, Shilpa Medicare Ltd has announced that the Subject ...

Shilpa Medicare has informed that the subject expert committee (Haematology) (SEC) has accepted the results of its Phase I clinical trials for Recombinant Human Albumin (rHA) 20% and granted approval ...

Campus Chemical Instrument Center, Mass Spectrometry & Proteomics Facility, The Ohio State University, Columbus, USA ...

was an acute shortage of human albumin. “This vital supplement”, he explained, “is crucial for patients with low blood volume, inadequate albumin production, or those recovering from major ...

Purpose: The technical issues surrounding the use of albumin in parenteral nutrient (PN) solutions are reviewed. Summary: Five criteria have been suggested to determine which compounds are optimal ...

A paper published in Gravitational and Space Research unveils insights gained from International Space Station ...

So, when I heard three aestheticians in separate aesthetic practices wax poetic about Plated Skin Science’s Intense Serum, an exosome- and antioxidant-rich serum powered by the brand’s ...